JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
The effect of the pretreatment systemic immune-inflammatory index and C-reactive protein-to-albumin ratio on prognosis in pediatric patients with IgA vasculitis
Aims: Indices related to blood parameters that indicate inflammation have recently started to be used in determining prognosis for many diseases. Visceral involvement is the most important factor affecting prognosis in immunoglobulin A vasculitis (IgAV). In this study, we sought to explore the value of the systemic immune-inflammation index (SII) and the C-reactive protein-to-albumin ratio (CAR) in predicting visceral involvement in IgAV. Material and
Methods: Patients diagnosed with IgAV who had gastrointestinal, renal, testicular, or central nervous system involvement were considered patients with visceral involvement. All patients with IgAV were divided into two groups, those with and without visceral involvement. The effect of SII and CAR in predicting visceral involvement was evaluated by logistic regression analysis.
Results: We found that in the summertime, the percentage of patients with visceral involvement was significantly higher than those without visceral involvement (p=0.010). The rates of the recurrence of the disease, arthralgia, arthritis, and fever were significantly greater in those with visceral involvement (p=0.032, p<0.001, p=0.027, and p=0.019, respectively). SII, CAR, and neutrophil-to-lymphocyte ratio (NLR) values were significantly higher in the patients with visceral involvement (p=0.017, p=0.046, and p=0.008, respectively). The results of the univariate analysis showed that the SII and NLR were significant predictors of visceral involvement (OR: 1.001, 95% CI: 1.000-1.001, p=0.036; OR: 1.344, 95% CI: 1.053-1.715, p=0.018, respectively). We found that NLR was of greater value than SII in terms of predicting visceral involvement.
Conclusion: SII can be a valuable indicator for predicting visceral involvement in IgAV. However, CAR was not found significant in predicting visceral involvement.


1. Batu ED, Ozen S. Pediatric vasculitis. Curr Rheumatol Rep 2012;14: 121-9.
2. L&oacute;pez-Mej&iacute;as R, Casta&ntilde;eda S, Genre F, et al. Genetics ofimmunoglobulin-A vasculitis (Henoch-Sch&ouml;nlein purpura): Anupdated review. Autoimmun Rev 2018; 17: 301-15.
3. Ekinci RMK, Balci S, Bisgin A, et al. MEFV gene variants inchildren with Henoch-Sch&ouml;nlein purpura and association withclinical manifestations: a single-center Mediterranean experience.Postgrad Med 2019; 131: 68-72.
4. Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schonleinpurpura in childhood: clinical analysis of 254 cases over a 3-yearperiod. Clin Rheumatol 2008; 27: 1087-92.
5. Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpurain childhood: epidemiological and clinical analysis of 150 casesover a 5-year period and review of literature. Semin ArthritisRheum 2005; 35: 143-53.
6. Coppo R, Andrulli S, Amore A, et al. Predictors of outcome inHenoch-Sch&ouml;nlein nephritis in children and adults. Am J KidneyDis 2006; 47: 993-1003.
7. Hocevar A, Rotar Z, Ostrovr&scaron;nik J,et al. Incidence of IgAvasculitis in the adult Slovenian population. Br J Dermatol 2014;171: 524-7.
8. Shin JI, Kim JH, Lee JS, Kim DS, Choi JY, Sul JH. Cardiacmanifestations of Henoch-Schoenlein purpura: IgA mediatedvasculitis or rheumatic fever? Eur J Pediatr 2007; 166: 627.
9. Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic valuesof inflammation-based makers in patients with HBV-relatedacute-on-chronic liver failure. Medicine (Baltimore) 2018; 97:13324.
10. Park CH, Han DS, Jeong JY, et al. The optimal cut-off value ofneutrophil-to-lymphocyte ratio for predicting prognosis in adultpatients with Henoch-Sch&ouml;nlein purpura. PLoS One 2016; 11:0153238.
11. Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyteratio (PLR) is superior to neutrophil lymphocyte ratio (NLR)as a predictive factor in patients with esophageal squamous cellcarcinoma. World J Surg Oncol 2014; 12: 58.
12. Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic valueof Systemic immune-inflammation index in cancer: A meta-analysis. J Cancer 2018 7; 9: 3295-302.
13. Wu J, Yan L, Chai K. Systemic immune-inflammation indexis associated with disease activity in patients with ankylosingspondylitis. J Clin Lab Anal 2021; 35: 23964.
14. Yorulmaz A, Hayran Y, Akpinar U, et al. Systemic immune-inflammation index (SII) predicts increased severity in psoriasisand psoriatic arthritis. Curr Health Sci J 2020; 46: 352-7.
15. Chen JB, Tang R, Zhong Y, et al. Systemic immune-inflammationindex predicts a reduced risk of end-stage renal disease in Chinesepatients with myeloperoxidase-anti-neutrophil cytoplasmicantibody-associated vasculitis: A retrospective observationalstudy. Exp Ther Med 2021; 22: 989.
16. Lapic I, Padoan A, Bozzato D, Plebani M. ErythrocyteSedimentation Rate and C-Reactive Protein in AcuteInflammation. Am J Clin Pathol 2020; 153: 14-29.
17. Don BR, Kaysen G. Serum albumin: relationship to inflammationand nutrition. Semin Dial 2004; 17: 432-7.
18. Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of amodified early warning system for acute medical admissions andcomparison with C-reactive protein/albumin ratio as a predictorof patient outcome. Clin Med (Lond) 2009; 9: 30-3
19. Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score,predicts outcomes in patients with hepatocellular carcinoma. AnnSurg Oncol 2015; 22: 803-10.
20. Moon JS, Ahn SS, Park YB, Lee SK, Lee SW. C-reactive proteinto serum albumin ratio is an independent predictor of all-causemortality in patients with ANCA-associated vasculitis. YonseiMed J 2018; 59: 865-71.
21. Tanacan E, Dincer D, Erdogan FG, Gurler A. A cutoff value for theSystemic Immune-Inflammation Index in determining activity ofBeh&ccedil;et disease. Clin Exp Dermatol 2021; 46: 286-91.
22. Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Schonleinpurpura in children. J Clin Rheumatol 2007; 13: 25-8.
23. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PREScriteria for Henoch-Sch&ouml;nlein purpura, childhood polyarteritisnodosa, childhood Wegener granulomatosis and childhoodTakayasu arteritis: Ankara 2008. Part II: Final classificationcriteria. Ann Rheum Dis 2010; 69: 798-806.
24. Du L, Wang P, Liu C, Li S, Yue S, Yang Y. Multisystemicmanifestations of IgA vasculitis. Clin Rheumatol 2021; 40: 43-52.
25. Fu W, Ye W, Liu X, et al. Meta-analysis of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Henoch-Schonlein purpura and its complications. Int Immunopharmacol2021; 94: 107454.
26. Leung AKC, Barankin B, Leong KF. Henoch-Sch&ouml;nlein purpurain children: an updated review. Curr Pediatr Rev 2020; 16: 265-76.
27. Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammationindex for predicting prognosis of colorectal cancer. World JGastroenterol 2017; 23: 6261-72.
28. Tian Y, Liu N, Yin H, Duan L. Relationship between C-reactiveprotein/serum albumin ratio, neutrophil/lymphocyte ratio, andANCA-associated vasculitis activity: a retrospective single centercohort study. Front Med (Lausanne) 2022; 9: 855869.
29. Kim Y, Choi H, Jung SM, Song JJ, Park YB, Lee SW. Systemicimmune-inflammation index could estimate the cross-sectionalhigh activity and the poor outcomes in immunosuppressivedrug-na&iuml;ve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 2019; 24: 711-7.
30. Ozen S. The spectrum of vasculitis in children. Best Pract Res ClinRheumatol 2002; 16: 411-25.
31. Chen SY, Kong MS. Gastrointestinal manifestations andcomplications of Henoch-Sch&ouml;nlein purpura. Chang Gung MedJ 2004; 27: 175-81.
32. Tabel Y, Inanc FC, Dogan DG, Elmas AT. Clinical features ofchildren with Henoch-Schonlein purpura: risk factors associatedwith renal involvement. Iran J Kidney Dis 2012; 6: 269-74.
33. Chan H, Tang YL, Lv XH, et al. Risk Factors Associated withRenal Involvement in Childhood Henoch-Sch&ouml;nlein Purpura: AMeta-Analysis. PLoS One 2016: 30; 11: e0167346.
34. Uppal SS, Hussain MA, Al-Raqum HA, et al. Henoch-Sch&ouml;nlein&#39;spurpura in adults versus children/adolescents: A comparativestudy. Clin Exp Rheumatol 2006; 24: 26-30.
35. Fretzayas A, Sionti I, Moustaki M, Papadimitriou A, NicolaidouP. Henoch-Sch&ouml;nlein purpura: a long-term prospective study inGreek children. J Clin Rheumatol 2008; 14: 324-31.
36. Karadağ ŞG, Tanatar A, S&ouml;nmez HE, et al. The clinical spectrumof Henoch-Sch&ouml;nlein purpura in children: a single-center study.Clin Rheumatol 2019; 38: 1707-14.
37. Calvo-R&iacute;o V, Hern&aacute;ndez JL, Ortiz-Sanju&aacute;n F, et al. Relapses inpatients with Henoch-Sch&ouml;nlein purpura: Analysis of 417 patientsfrom a single center. Medicine (Baltimore) 2016; 95: 4217.
38. Demirtaş Ş, Dursun İ, Pınarbaşı AS, et al. The Factors Affecting theOccurrence of Renal Involvement in Children with IgA Vasculitis:Renal Involvement of IgA Vasculitis. J Pediatr Acad 2020; 1: 50-5.
39. Bogdanovic R. Henoch-Sch&ouml;nlein purpura nephritis in children:risk factors, prevention and treatment. Acta Paediatr 2009; 98:1882-9.
40. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renalinvolvement and significant proteinuria in Henoch-Sch&ouml;nleinpurpura. Eur J Pediatr 2002; 161: 196-201.
41. Assulyn T, Khamisy-Farah R, Nseir W, Bashkin A, Farah R.Neutrophil-to-lymphocyte ratio and red blood cell distributionwidth as predictors of microalbuminuria in type 2 diabetes. J ClinLab Anal 2020; 34: 23259.
42. Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG,Azevedo CHM, Monteiro MC. Immune modulation of someautoimmune diseases: the critical role of macrophages andneutrophils in the innate and adaptive immunity. J Transl Med2017; 15: 36.
43. Barut K, Sahin S, Kasapcopur O. Pediatric vasculitis. Curr OpinRheumatol 2016; 28: 29-38.
44. &Ouml;zdemir ZC, &Ccedil;etin N, Kar YD, &Ouml;cal HO, Bilgin M, B&ouml;r &Ouml;.Hemotologic indices for predicting internal organ involvementin Henoch-Sch&ouml;nlein purpura (IgA vasculitis). J Pediatr HematolOncol 2020; 42: 46-49.
45. Jagroop IA, Clatworthy I, Lewin J, Mikhailidis DP. Shape changein human platelets: measurement with a channelyzer andvisualisation by electron microscopy. Platelets 2000; 11: 28-32.
46. Edstr&ouml;m Halling S, S&ouml;derberg MP, Berg UB. Predictors of outcomein Henoch-Sch&ouml;nlein nephritis. Pediatr Nephrol 2010; 25: 1101-8.
47. Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammationindex (SII) predicted clinical outcome in patients with coronaryartery disease. Eur J Clin Invest 2020; 50: 13230.
48. Fois AG, Paliogiannis P, Scano V, et al. The systemicınflammation ındex on admission predicts ın-hospital mortalityin COVID-19 patients. Molecules 2020; 25: 5725. doi: 10.3390/molecules25235725.
49. G&uuml;neylioğlu MM, G&uuml;ng&ouml;r A, G&ouml;ktuğ A, et al. Evaluation ofthe efficiency of the systemic immune-inflammation index indifferentiating parapneumonic effusion from empyema. PediatrPulmonol 2022; 57: 1625-30.
50. Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M.C-reactive protein/albumin ratio predicts 90-day mortality ofseptic patients. PLoS One 2013; 8: 59321.
51. Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammationindex for predicting prognosis of colorectal cancer. World JGastroenterol 2017; 23: 6261-72.
Volume 6, Issue 2, 2023
Page : 441-448
_Footer